Mark Krogh Hvistendahl

3PUBLICATIONS
3CO-AUTHORS
GlycoconjugatesGastroenterology and hepatologyFood properties (incl. characteristics and health benefits)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|May 05, 2022
Effects of glepaglutide, a long-acting glucagon-like peptide-2 analog, on intestinal morphology and perfusion in patients with short bowel syndrome: Findings from a randomized phase 2 trial.

Rahim M Naimi, Mark K Hvistendahl, Steen S Poulsen

|Jul 21, 2021
Bile acid-farnesoid X receptor-fibroblast growth factor 19 axis in patients with short bowel syndrome: The randomized, glepaglutide phase 2 trial.

Mark Krogh Hvistendahl, Rahim Mohammad Naimi, Svend Høime Hansen

|Feb 06, 2020
Effect of Glepaglutide, a Long-Acting Glucagon-Like Peptide-2 Analog, on Gastrointestinal Transit Time and Motility in Patients With Short Bowel Syndrome: Findings From a Randomized Trial.

Mark Krogh Hvistendahl, Rahim Mohammad Naimi, Lotte Hahn Enevoldsen

Pageof 1

Frequent Collaborators

2 joint publications

Rahim Mohammad Naimi

2 joint publications

Hannelouise Kissow

2 joint publications

Palle Bekker Jeppesen